Stainless Foundry & Engineering helps develop antimicrobial stainless steel

According to a release from Advancing Medical Innovations (AMI) in Hingham, Massachusetts, Performance Compounds Inside (PCI) has made historic advancements in metallurgy with its 3PRE Technology, a novel and proprietary process of activating antimicrobial properties. 

PCI’s first use of its 3PRE Technology is with molybdenum, an essential element. When activated through 3PRE Technology, molybdenum takes on antimicrobial properties and can be added to stainless steel during the foundry process to render it capable of destroying and inhibiting bacteria and other disease-causing microorganisms. The result is a stainless steel that retains the characteristics of 304 and 316 stainless steel while also imbuing antimicrobial properties directly and thoroughly into the steel––not as a coating.

“Our foundry is pleased to have been involved in the manufacture of the first antimicrobial stainless steel. We are impressed with the homogeneity and consistency of the end product and can anticipate multiple uses across any number of industries,” said Jim Stachowiak, president & CEO of Stainless Foundry & Engineering (Milwaukee, Wisconsin). 

Dr. Amod Paranjpe, co-founder and researcher at PCI said, “This is the first time a stainless steel has been manufactured with antimicrobial properties at the foundry process level. Activation of 3PRE within the steel enables a bactericidal effect with an extremely high 24-hour kill rate. 

“We anticipate this process would be equally effective with any form of steel product,” Paranjpe added. 3PRE Technology carries significant IP protection and can be used to imbue a range of materials with antimicrobial protection.

AMI and PCI are actively seeking licensing partners for this antimicrobial technology. Inquire at    CS